Effect of recombinant murine granulocyte colony-stimulating factor with or without fluoroquinolone therapy on mixed-infection abscesses in mice

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 9, 2005, Pages 3668-3675

  Stearne, Lorna E T ^a,d   Vonk, Alieke G ^b,c   Kullberg, Bart Jan ^b   Gyssens, Inge C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Cromwell House   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SODIUM CHLORIDE; TROVAFLOXACIN; TUMOR NECROSIS FACTOR ALPHA;

ABSCESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL OVERGROWTH; BACTERIAL VIRULENCE; BACTEROIDES FRAGILIS; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; ESCHERICHIA COLI; FEMALE; GRANULOCYTE; HOST RESISTANCE; IMMUNOMODULATION; MALE; MINIMUM INHIBITORY CONCENTRATION; MIXED INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME;

ABSCESS; ANIMALS; ANTI-INFECTIVE AGENTS; AZA COMPOUNDS; BACILLUS; COLONY COUNT, MICROBIAL; CYTOKINES; ESCHERICHIA COLI; FEMALE; FLUOROQUINOLONES; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; QUINOLINES; SPLEEN; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 24144465140     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.9.3668-3675.2005     Document Type: Article

References (29)

1. Abdul-Majid, K. B., P. A. Kenny, and J. J. Finlay-Jones. 1997. The effect of the bacterial product, succinic acid, on neutrophil bactericidal activity. FEMS Immunol. Med. Microbiol. 17:79-86.
2. Araujo, F. G., T. L. Slifer, and J. S. Remington. 2002. Effect of moxifloxacin on secretion of cytokines by human monocytes stimulated with lipopolysaccharide. Clin. Microbiol. Infect. 8:26-30.
3. Barsig, J., D. S. Bundschuh, T. Hartung, A. Bauhofer, A. Sauer, and A. Wendel. 1996. Control of fecal peritoneal infection in mice by colony-stimulating factors. J. Infect. Dis. 174:790-799.
4. Dalhoff, A., and I. Shalit. 2003. Immunomodulatory effects of quinolones. Lancet 3:359-371.
5. Finlay-Jones, J. J., K. V. L. Davies, L. P. Sturm, P. A. Kenny, and P. H. Hart. 1999. Inflammatory processes in a murine model of intra-abdominal abscess formation. J. Leukoc. Biol. 66:583-587.
6. Gorgen, I., T. Hartung, M. Leist, M. Niehorster, G. Tiegs, S. Uhlig, F. Weitzel, and A. Wendel. 1992. Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-alpha. J. Immunol. 149:918-924.
7. Karzai, W., B. U. von Specht, C. Parent, J. Haberstroh, K. Wollersen, C. Natanson, S. M. Banks, and P. Q. Eichacker. 1999. G-CSF during Escherichia coli versus Staphylococcus aureus pneumonia in rats has fundamentally different and opposite effects. Am. J. Respir. Crit. Care Med. 159:1377-1382.
8. Khan, A. A., T. L. Slifer, and J. S. Remington. 1998. Effect of trovafloxacin on production of cytokines by human monocytes. Antimicrob. Agents Chemother. 42:1713-1717.
9. Konig, B., W. Konig, J. Scheffer, J. Hacker, and W. Goebel. 1986. Role of Escherichia coli alpha-hemolysin and bacterial adherence in infection: requirement for release of inflammatory mediators from granulocytes and mast cells. Infect. Immun. 54:886-892.
10. Lundblad, R., J. M. Nesland, and K.-E. Giercksky. 1996. Granulocyte colony-stimulating factor improves survival rate and reduces concentrations of bacteria, endotoxin, tumor necrosis factor, and endothelin-1 in fulminant intra-abdominal sepsis in rats. Crit. Care Med. 24:820-826.
11. McClean, K. L., G. J. Sheehan, and G. K. M. Harding. 1994. Intra-abdominal Infection: a review. Clin. Infect. Dis. 19:100-116.
12. Netea, M. G., P. N. Demacker, B. J. Kullberg, O. C. Boerman, I. Verschueren, A. F. Stalenhoef, and J. W. van der Meer. 1996. Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections. J. Clin. Investig. 97:1366-1372.
13. Nielsen, S. L., N. Obel, M. Storgaard, and P. L. Andersen. 1997. The effect of quinolones on the intracellular killing of Staphylococcus aureus in neutrophil granulocytes. J. Antimicrob. Chemother. 39:617-622.
14. Pascual, A., I. Garcia, S. Ballesta, and E. J. Perea. 1999. Uptake and intracellular activity of moxifloxacin in human phagocytes and tissue-cultured epithelial cells. Antimicrob. Agents Chemother. 43:12-15.
15. Pascual, A., I. Garcia, S. Ballesta, and E. J. Perea. 1997. Uptake and intracellular activity of trovafloxacin in human phagocytes and tissue-cultured epithelial cells. Antimicrob. Agents Chemother. 41:274-277.
16. Quezado, Z., C. Parent, W. Karzai, M. Depietro, C. Natanson, W. Hammond, R. L. Danner, X. Cui, Y. Fitz, S. M. Banks, E. Gerstenberger, and P. Q. Eichacker. 2001. Acute G-CSF therapy is not protective during lethal E. coli sepsis. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 281: R1177-R1185.
17. Rubinstein, E., L. Diamantstein, G. Yoseph, G. Gruzman, B. Rubinovitch, A. Barzilai, and N. Keller. 2000. The effect of albumin globulin, pus and dead bacteria in aerobic and anaerobic conditions on the antibacterial activity of moxifloxacin, trovafloxacin and ciprofloxacin against Streptococcus pneumoniae, Staphylococcus aureus and E. coli. Clin. Microbiol. Infect. 6:675-686.
18. Saba, R., M. Guler, D. Inan, D. Ogunc, S. Atalay, L. Mamikoglu, and F. Gunseren. 2003. The effect of granulocyte colony-stimulating factor in the treatment of Escherichia coli peritonitis with or without ceftriaxone in a nonneutropenic rat model. Surg. Today 33:504-508.
19. Shalaby, M. R., B. B. Aggarwal, E. Rinderknecht, L. P. Sverdersky, B. S. Finkle, and J. Palladino. 1985. Activation of human polymorrphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. J. Immunol. 135:2069-2073.
20. Shalit, I., Y. Kletter, D. Halperin, D. Waldman, E. Vasserman, A. Nagler, and I. Fabian. 2001. Immunomodulatory effects of moxifloxacin in comparison to ciprofloxacin and G-CSF in a murine model of cyclophosphamide-induced leukopenia. Eur. J. Haematol. 66:287-296.
21. Siefert, H. M., A. Domdey-Bette, K. Henninger, F. Hucke, C. Kohlsdorfer, and H. H. Stass. 1999. Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: a comparison in humans and other mammalian species. J. Antimicrob. Chemother. 43(Suppl. B):69-76.
22. Stearne, L. E. T., S. L. Buijk, J. W. Mouton, and I. C. Gyssens. 2002. Effect of a single percutaneous abscess drainage puncture and imipenem therapy, alone or in combination, in treatment of mixed-infection abscesses in mice. Antimicrob. Agents Chemother. 46:3712-3718.
23. Stearne, L. E. T., I. C. Gyssens, W. H. Goessens, J. W. Mouton, W. J. Oyen, J. W. van der Meer, and H. A. Verbrugh. 2001. In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infections with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model. Antimicrob. Agents Chemother. 45:1394-1401.
24. Stearne, L. E. T., C. Kooi, W. H. Goessens, I. A. J. M. Bakker-Woudenberg, and I. C. Gyssens. 2001. In vitro activity of trovafloxacin against Bacteroides fragilis in mixed culture with either Escherichia coli or a vancomycin resistant strain of Enterococcus faecium using an anaerobic time kill technique. Antimicrob. Agents Chemother. 45:243-251.
25. Vignes, S., B. Fantin, C. Elbim, F. Walker, M.-A. Gougerot-Pocidalo, and C. Carbon. 1995. Critical influence of timing of administration of granulocyte colony-stimulating factor on antibacterial effect in experimental endocarditis due to Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 39:2702-2707.
26. Villa, P., L. Shaklee, C. Meazza, D. Agnello, P. Ghezzi, and G. Sendaldi. 1998. Granulocyte colony-stimulating factor and antibiotics in the prophylaxis of a murine model of polymicrobial peritonitis and sepsis. J. Infect. Dis. 178:471-477.
27. Vonk, A. G., M. G. Netea, J. H. van Krieken, P. E. Verweij, J. W. van der Meer, and B. J. Kullberg. 2003. Treatment of intra-abdominal abscesses caused by Candida albicans with antifungal agents and recombinant murine granulocyte colony-stimulating factor. Antimicrob. Agents Chemother. 47:3688-3693.
28. Wright, S. D., R. A. Ramos, A. Hermanowski-Vosatka, P. Rockwell, and P. A. Detmers. 1991. Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: dependence on lipopolysaccharide binding protein and CD14. J. Exp. Med. 173:1281-1286.
29. Yagisawa, M., A. Yuo, S. Kitagawa, Y. Yazaki, and F. Takaku. 1995. Stimulation and priming of human neutrophils by IL-1 alpha and IL-1 beta: complete inhibition by IL-1 receptor antagonist and no interaction with other cytokines. Exp. Hematol. 23:603-608.